Express Scripts’ Miller backs new pricing models for CAR T, gene therapy

In a blog post, Express Scripts Holding Co. (NASDAQ:ESRX) CMO Steve Miller called for new drug pricing and payment models for one-time, potentially curative treatments.

Miller said that while therapies such as Kymriah

Read the full 326 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE